Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 103

Dentsu goes with gut in $83m uBiome round

Microbial diagnostics and wellness product developer uBiome has received series C funding in a Dentsu Ventures-backed round.

Sep 25, 2018

Telstra helps Singular sink $30m

The marketing data software provider increased its overall funding to $50m in a series B round featuring returning investor Telstra Ventures.

Sep 25, 2018

Origami scans corporates for series C funding

Nihon Unisys, Mitsui Sumitomo Card Company, Union Pay, JCB and Credit Saison all backed a $66.6m round for the mobile payment platfrom.

Sep 25, 2018

Principia achieves $122m IPO

Principia Biopharma, whose drug discovery platform is based on research at UCSF, has completed a $122m initial public offering after underwriters exercised their greenshoe option.

Sep 25, 2018

Ola navigates $1bn round

Naspers and Temasek are discussing an investment of $1bn in Ola that would value the ride-sharing firm at $7bn to $8bn.

Sep 25, 2018

Oyo to accomodate $1bn

SoftBank Vision Fund has contributed to an initial $800m tranche, with more than half of the round allocated to Oyo's expansion across China.

Sep 25, 2018

SI-Bone to connect itself to public markets

The Novo-backed medical implant provider has filed to raise up to $97.8m in an initial public offering that comes after $103m in funding.

Sep 25, 2018

CapitalG joins Convoy for $185m series C

Trucking services platform Convoy increased its total funding to $265m in a CapitalG-led round that valued it at $1bn.

Sep 25, 2018

MIT’s Engine hits $205m close

The MIT-affiliated Engine Fund has achieved a final close of more than $205m, above its initial target of $150m.

Sep 25, 2018

Asarina diagnoses listing

Karolinska Development has celebrated an exit as Umeå spinout Asarina Pharma went public in Sweden after raising $16.3m in its initial public offering.

Sep 25, 2018
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here